Position in JNJ
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$577,640,796
-$74,266,261 QoQ
Shares Held
2,274,445
-14.7% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#87
of 4,676 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 31%
Shared 2%
None 67%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$2,836,926
PutShares
15,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $2,580,155,060 across 16 Drug Manufacturers - General names. JNJ ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
592,599 | $710,781,077 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,274,445 | $577,640,796 | |
| 3 | ABBV |
AbbVie Inc.
|
2,063,716 | $519,313,494 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,391,313 | $307,283,720 | |
| 5 | AMGN |
Amgen Inc
|
466,785 | $169,032,183 | |
| 6 | NVS |
Novartis AG
|
437,208 | $68,519,237 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
538,310 | $68,010,084 | |
| 8 | PFE |
Pfizer Inc
|
2,547,672 | $61,347,940 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $577,640,796 | 2,274,445 | Shares | Sole | 2026-08-27 | |
| 2026-03-31 | $651,907,057 | 2,666,941 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $560,331,404 | 2,707,569 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $2,836,926 | 15,300 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $481,588,397 | 2,597,284 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $341,798,745 | 2,237,635 | Shares | Other | 2025-09-26 | |
| 2025-03-31 | $370,953,066 | 2,236,813 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $355,028,069 | 2,454,903 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $453,091,560 | 2,795,826 | Shares | Other | 2024-11-12 | |
| 2024-09-30 | $2,463,312 | 15,200 | Put | Sole | 2024-11-12 | |
| 2024-06-30 | $392,021,436 | 2,682,139 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $444,407,437 | 2,809,327 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $442,562,129 | 2,823,543 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $420,028,624 | 2,696,813 | Shares | Other | 2023-11-03 | |
| 2023-09-30 | $501 | 15,900 | Put | Sole | 2023-11-03 | |
| 2023-06-30 | $437,277,686 | 2,641,842 | Shares | Other | 2023-08-10 | |
| 2023-03-31 | $411,280,410 | 2,653,422 | Shares | Other | 2023-05-15 | |
| 2023-03-31 | $2,464,500 | 15,900 | Put | Sole | 2023-05-15 | |
| 2022-12-31 | $2,808,735 | 15,900 | Put | Sole | 2023-02-15 | |
| 2022-12-31 | $330,334,263 | 1,869,993 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||